Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Equity Insider News Commentary – Major cybersecurity agencies warn that adversaries are currently exfiltrating and storing sensitive...
-
MONTRÉAL, Dec. 16, 2025 (GLOBE NEWSWIRE) -- OR Royalties Inc. (“OR Royalties” or the “Company”) (OR: TSX & NYSE) is pleased to provide the following select asset updates. Amounts presented...
-
Chicago, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The global advanced recycling market was valued at US$ 2.8 billion in 2025 and is expected to reach US$ 10.2 billion by 2035, growing at a CAGR of 13.9%...
-
Rail Vision Enters the Quantum Transportation Market with Strategic Acquisition Agreement Ra’anana, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision” or the...
-
MIAMI, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) today named travel industry veteran Marc Kazlauskas as President of Norwegian Cruise Line (Norwegian),...
-
New York, USA, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Celiac disease...
-
Société anonyme au capital de 14 155 547,94 euros Siège Social : 92 Boulevard du Montparnasse75014 Paris R.C.S. Paris 572 230 829 RAPPORT SEMESTRIEL AU 30 SEPTEMBRE 2025 Sommaire ...
-
Proposes Change of Business to a mining/investment issuerAdds renowned geologist Dr. Quinton Hennigh as Investment AdvisorMr. Kevin Ramsay, CPA, CA, will join the Board of DirectorsAnnual General and...
-
HERZLIYA, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement and payments platform designed to help merchants scale their business by...
-
Partnership with Kelun-Biotech expands pipeline and accelerates combination strategy with CR-001, a PD-1 x VEGF bispecific antibody, and multiple antibody-drug conjugates (ADCs), generating clinical...